These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6333496)

  • 1. (3-N-[11C]methyl)spiperone, a ligand binding to dopamine receptors: radiochemical synthesis and biodistribution studies in mice.
    Burns HD; Dannals RF; Langström B; Ravert HT; Zemyan SE; Duelfer T; Wong DF; Frost JJ; Kuhar MJ; Wagner HN
    J Nucl Med; 1984 Nov; 25(11):1222-7. PubMed ID: 6333496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No-carrier-added fluorine-18-labeled N-methylspiroperidol: synthesis and biodistribution in mice.
    Shiue CY; Fowler JS; Wolf AP; McPherson DW; Arnett CD; Zecca L
    J Nucl Med; 1986 Feb; 27(2):226-34. PubMed ID: 3712039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of dopamine receptor densities in the human brain with carbon-11-labeled N-methylspiperone.
    Wagner HN; Burns HD; Dannals RF; Wong DF; Langström B; Duelfer T; Frost JJ; Ravert HT; Links JM; Rosenbloom SB
    Ann Neurol; 1984; 15 Suppl():S79-84. PubMed ID: 6611131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [11C]spiroperidol: synthesis, specific activity determination, and biodistribution in mice.
    Fowler JS; Arnett CD; Wolf AP; MacGregor RR; Norton EF; Findley AM
    J Nucl Med; 1982 May; 23(5):437-45. PubMed ID: 6281403
    [No Abstract]   [Full Text] [Related]  

  • 5. Characteristics of specific in vivo labeling of neuroleptic binding sites with 3-N-[11C]methylspiperone.
    Yanai K; Ido T; Ishiwata K; Hatazawa J; Watanuki S; Takahashi T; Ujiie A; Ito M; Matsuzawa T
    Eur J Nucl Med; 1986; 11(11):438-43. PubMed ID: 3486764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of N-methyl and N-11C-methyl spiperone by phase transfer catalysis in anhydrous solvent.
    Omokawa H; Tanaka A; Iio M; Nishihara Y; Inoue O; Yamazaki T
    Radioisotopes; 1985 Sep; 34(9):480-5. PubMed ID: 4089233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo binding of spiperone and N-methylspiperone to dopaminergic and serotonergic sites in the rat brain: multiple modeling and implications for PET scanning.
    Swart JA; van der Werf JF; Wiegman T; Paans AM; Vaalburg W; Korf J
    J Cereb Blood Flow Metab; 1990 May; 10(3):297-306. PubMed ID: 1970341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of 3-N-[11C]methylspiperone with high specific activity and high radiochemical purity for PET studies: suppression of its radiolysis.
    Suzuki K; Inoue O; Tamate K; Mikado F
    Int J Rad Appl Instrum A; 1990; 41(6):593-9. PubMed ID: 1972936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging dopamine receptors in the human brain by positron tomography.
    Wagner HN; Burns HD; Dannals RF; Wong DF; Langstrom B; Duelfer T; Frost JJ; Ravert HT; Links JM; Rosenbloom SB; Lukas SE; Kramer AV; Kuhar MJ
    Science; 1983 Sep; 221(4617):1264-6. PubMed ID: 6604315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-(3-[18F]fluoropropyl)-spiperone: the preferred 18F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor.
    Welch MJ; Katzenellenbogen JA; Mathias CJ; Brodack JW; Carlson KE; Chi DY; Dence CS; Kilbourn MR; Perlmutter JS; Raichle ME
    Int J Rad Appl Instrum B; 1988; 15(1):83-97. PubMed ID: 3258305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-(2'-[18F]fluoroethyl)spiperone: in vivo biochemical and kinetic characterization in rodents, nonhuman primates, and humans.
    Barrio JR; Satyamurthy N; Huang SC; Keen RE; Nissenson CH; Hoffman JM; Ackermann RF; Bahn MM; Mazziotta JC; Phelps ME
    J Cereb Blood Flow Metab; 1989 Dec; 9(6):830-9. PubMed ID: 2531146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptors in pituitary adenomas: PET visualization with 11C-N-methylspiperone.
    Muhr C; Bergström M; Lundberg PO; Bergström K; Hartvig P; Lundqvist H; Antoni G; Långström B
    J Comput Assist Tomogr; 1986; 10(2):175-80. PubMed ID: 3485123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 76Br-bromospiroperidol: a new tool for quantitative in-vivo imaging of neuroleptic receptors.
    Mazière B; Loc'h C; Hantraye P; Guillon R; Duquesnoy N; Soussaline F; Naquet R; Comar D; Mazière M
    Life Sci; 1984 Sep; 35(13):1349-56. PubMed ID: 6332966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No-carrier-added 3-(2'-[18F]fluoroethyl)spiperone, a new dopamine receptor-binding tracer for positron emission tomography.
    Satyamurthy N; Bida GT; Barrio JR; Luxen A; Mazziotta JC; Huang SC; Phelps ME
    Int J Rad Appl Instrum B; 1986; 13(6):617-24. PubMed ID: 3494003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-N-(2-[18F]-fluoroethyl)-spiperone: a novel ligand for cerebral dopamine receptor studies with pet.
    Coenen HH; Laufer P; Stöcklin G; Wienhard K; Pawlik G; Böcher-Schwarz HG; Heiss WD
    Life Sci; 1987 Jan; 40(1):81-8. PubMed ID: 2948091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m spiperone dithiocarbamate: a potential radiopharmaceutical for dopamine receptor imaging with SPECT.
    Ballinger JR; Gulenchyn KY; Hassan MN
    Int J Rad Appl Instrum A; 1989; 40(6):547-9. PubMed ID: 2551854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improved synthesis of (3-N-[11C]methyl)spiperone.
    Dannals RF; Ravert HT; Wilson AA; Wagner HN
    Int J Rad Appl Instrum A; 1986; 37(5):433-4. PubMed ID: 3019944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iodoethylspiperone, a new potential agent for exploration of central dopamine D2 receptors: synthesis and preliminary in vivo study.
    Chalon S; Frangin Y; Guilloteau D; Caillet M; Guimbal C; Schmitt MH; Desplanches G; Baulieu JL; Besnard JC
    Int J Rad Appl Instrum B; 1990; 17(4):389-95. PubMed ID: 2143754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3-(2'-[18F]fluoroethyl)spiperone, a potent dopamine antagonist: synthesis, structural analysis and in-vivo utilization in humans.
    Satyamurthy N; Barrio JR; Bida GT; Huang SC; Mazziotta JC; Phelps ME
    Int J Rad Appl Instrum A; 1990; 41(2):113-29. PubMed ID: 2158942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positron emission tomography (PET) in the study of dopamine receptors in the primate brain: evaluation of a kinetic model using 11C-N-methyl-spiperone.
    Eckernäs SA; Aquilonius SM; Hartvig P; Hägglund J; Lundqvist H; Någren K; Långström B
    Acta Neurol Scand; 1987 Mar; 75(3):168-78. PubMed ID: 3495092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.